Salestools LogoSalestools
Agentes IA de Salestools
Soluciones
Recursos
Empresa
Precios
Salestools Logo

Salestools

El agente IA #1 para equipos de ventas y Go-to-Market. Vende más, más rápido, con menos esfuerzo.

Producto

  • Agentes de ventas IA
  • Datos de intención
  • Datos tecnológicos
  • Seguimiento de visitantes
  • Co-Pilot
  • Venta social

Soluciones

  • Servicio al cliente
  • Comercio electrónico
  • SaaS
  • Empresarial
  • Pequeña empresa

Recursos

  • El informe
  • Documentación
  • Referencia de API
  • Centro de ayuda
  • Blog
  • Casos de estudio
  • Webinars

Empresa

  • Acerca de
  • Carreras
  • Prensa
  • Contacto
  • Socios

Nuestras ubicaciones

  • Nueva York, HQ
  • Bucarest, laboratorio de investigación IA
  • Zug, Suiza

© 2025 Salestools. Todos los derechos reservados.

Términos de datos y seguridadPolítica de privacidadTérminos de servicio
Todos los sistemas operativos
Salestools LogoSalestools
Agentes IA de Salestools
Soluciones
Recursos
Empresa
Precios
Back to The Report
Fundraising

ElevenLabs

ElevenLabs Raises $180M in Series C

2022
Founded
80+
Employees
New York, NY
Updated October 12, 2025
2 min read

Quick Facts

ElevenLabs Raises $180M in Series C


ElevenLabs has successfully raised $180M in a Series C at a $3.3B valuation led by Andreessen Horowitz, Nat Friedman.


Company Overview


ElevenLabs is a AI/ML company headquartered in New York, NY, founded in 2022 with 80+ employees.


AI voice generation and cloning platform for content creators


Fundraising Details


  • Amount Raised: $180M
  • Round Type: Series C
  • Valuation: $3.3B
  • Date: 2025-10-12
  • Investors: Andreessen Horowitz, Nat Friedman

About ElevenLabs


AI voice generation and cloning platform for content creators The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: New York, NY
  • Founded: 2022
  • Team Size: 80+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in ElevenLabs's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. ElevenLabs's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $3.3B valuation marks an important milestone for ElevenLabs, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, ElevenLabs is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-10-12. For more information about ElevenLabs, visit their headquarters at New York, NY.

Topics

Fundraising(2912)AI/ML(481)Series C(291)ElevenLabs

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million